Agilent Technologies Inc. and Synthego Corp. sparred Friday over whether Agilent patents related to a key component of the ...

European Patent Office grants new CRISPR/Cas9 patent (EP 4 289 948) to CVC, with broad claims covering guide RNAs and their combination with Cas9. Patent strengthens CVC's leading position in ...

This is exemplified by granted US patent US11,517,582, which covers the use of CRISPR-Cas systems to achieve selective killing of bacteria by at least 1000-fold in situations where bacteria are ...

EPO grants new CRISPR/Cas9 patent to CVC, with broad claims covering guide RNAs and their combination with Cas9: Dublin, Ireland Friday, February 28, 2025, 14:00 Hrs [IST] ERS Gen ...

Carlyle Group's acquisition of bluebird bio for $3 per share offers a potential but unlikely $600 million sales milestone by ...

Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term momentum without new products.

In the last year, some drugmakers have pulled back from the sector, including Pfizer, which recently stopped selling its gene ...